Gene Query: PSG4

Dataset Description Geneva Score
RNA sequencing of human fibroblasts after SUPT4H1 siRNA treatment 399.88
RNA-seq of human fibroblasts after irradiation 170.85
In vivo genome editing restores dystrophin expression in Duchenne muscular dystrophy patient muscle fibers 113.73
Progesterone receptor transcriptome and cistrome in decidualized human endometrial stromal cells 86.16
FOXO1 is required for binding of PR on IRF4, novel transcriptional regulator of endometrial stromal decidualization 86.16
Progesterone Receptor- and FOXO1-dependent transcriptomes decidualized human endometrial stromal cells 86.16
Primary human trophoblast from term placenta 85.76
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation 79.99
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation [RNA-seq] 79.99
BAF controls genome accessibility 79.33
ELP1 splicing correction reverses proprioceptive sensory loss in familial dysautonomia 76.69
Deletions in the ATAD3 gene cluster cause cerebellar developmental defects with mitochondrial DNA abnormalities owing to local cholesterol insufficiency 74.79
Large-scale profiling of intracellular signalling pathway activation reveals major distinctions between airway smooth muscle cells of asthmatics and non-asthmatics. 72.09
Normal stroma suppresses cancer cell proliferation via mechanosensitive regulation of JMJD1a-mediated transcription [RNA-Seq] 68.91
Normal stroma suppresses cancer cell proliferation via mechanosensitive regulation of JMJD1a-mediated transcription 68.91
Safety profiling of genetically engineered Pim-1 kinase overexpression for oncogenicity risk in human c-kit+ cardiac interstitial cells 68.64
High-Throughput Drug Screening identifies Pazopanib and Clofilium tosylate as effective treatments for malignant rhabdoid tumors 65.61
G9a-Mediated Methylation of ERα Links the PHF20/MOF Histone Acetyltransferase Complex to Hormonal Gene Expression 63.77
Mammalian Hbs1L deficiency causes Pelota depletion and is associated with a unique phenotype 59.13
mTOR hyperactivation in Down Syndrome mediates deficits in autophagy induction, autophagosome formation, and mitophagy 58.37
The effect of PPARG inhibition on human angiomyolipoma cells 57.9
Integrative Genomic Analysis Reveals Widespread Enhancer Regulation by p53 in Response to DNA Damage 51.83
Expression by CD133+ cells isolated from the adult human exocrine pancreas 44.92
Integration of genome-wide DNA methylome and transcriptome of human intestinal fibroblasts reveals novel candidate gene signatures in Crohn’s disease-associated fibrosis 42.41
Transcriptomic analyssis following EHMT1/2 inhibition 41.95
Interferon-γ Converts Human Microvascular Pericytes into Negative Regulators of Alloimmunity through Induction of Indoleamine 2,3-Dioxygenase 1 41.51
Differential gene expression analysis between proliferating and quiescent human dermal fibroblasts 41.39
Epigenetic alterations affecting transcription factors and signaling pathways in stromal cells of endometriosis 38.55
Epigenetic alterations affecting transcription factors and signaling pathways in stromal cells of endometriosis: Expression data (RNA-seq) 38.55
A genome-wide long noncoding RNA CRISPRi screen identifies PRANCR as a novel regulator of epidermal homeostasis 38.18
Global gene expression differences between blood- and lymphatic-specific endothelial colony forming cells 37.2
Peroxisome Proliferator-activated Receptor gamma- Deficiency in Endothelial Cells Impairs Angiogenic Capacity by Loss-of E2F1 Mediated Wnt Effector Genes 35.79
Preliminary Report of Transplantation of Human Fetal Retinal Pigment Epithelial Cells on Age-related Macular Degeneration Patients 34.32
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_RNA-seq] 33.53
Proliferation pause as an early blockade of human cellular reprogramming toward pluripotency [RNA-seq analysis] 33.06
Maturation of human iNSCs 32.03
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation 29.55
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation [RNA-Seq] 29.55
mRNA expression profile of A549 cells and MSR-A549 cells with or without JQ1 treatment 27.41
A549 cells and MSR-A549 cells 27.41
RNA-Seq analysis of cSCC cells after siRNA-induced gene knockdown of lncRNA PRECSIT 26.96
Transcriptome analysis of virus infected tissues 26.43
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion 26.23
Investigation about fibroblasts of different origins in culture 25.96
MicroRNA targetome analysis during HCMV infection 24.9
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells 24.4
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells [RNA-seq] 24.4
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family (RNA-seq) 23.8
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family 23.8
Lentiviral CRISPR Epigenome Editing of Inflammatory Receptors as a Gene Therapy Strategy for Disc Degeneration 23.61
Bioinformatics analysis of transcriptome related to blood stasis syndrome in diabetes mellitus patients 23.61
Global gene expression differences between blood- and lymphatic-specific human dermal microvascular endothelial cells 23.5
A novel compound that blocks HIV-1 replication inhibits the splicing regulatory function of SRSF10 23.06
Toxoplasma gondii infection of human retinal pigment epithelial cells 22.43
CHD1 regulates cell fate determination by activation of differentiation-induced genes 22.15
Poly(A)-specific ribonuclease (PARN) mediates 3' end maturation of the telomerase RNA component 21.6
Transcriptome profiling of a mouse model of alveolar soft part sarcoma 21.47
Differential susceptibility of human pleural and peritoneal mesothelial cells to asbestos exposure 21.32
Impaired DNA damage metabolism promotes autoimmunity in TREX1 deficiency  20.89
Alu RNA modulates the expression of cell cycle genes in human fibroblasts 20.81
Recruiting Endogenous ADARs with Antisense Oligonucleotides to Reprogram the Transcriptome 20.24
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [IMR90_MCF7_RNA-Seq] 19.56
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone 19.56
Altered mRNA splicing by mutant p53 activates oncogenic RAS in pancreatic cancer 19.1
Dnmt3a and Dnmt3b associate with enhancers to regulate human epidermal stem cell homeostasis 18.94
Dual role of CSL (RBP-Jk) and NOTCH1 in cancer-associated fibroblast genome stability and expansion [RNA-seq] 18.11
Dual role of CSL (RBP-Jk) and NOTCH1 in CAF 18.11
Transcriptomic Profiling of Developing Human Paraxial Mesoderm from 4.5-5 Weeks of Gestation Human Embryos 18.04
Convergent roles of ATF3 and CSL in chromatin control of CAF activation [RNA-seq] 17.71
Convergent roles of ATF3 and CSL in chromatin control of CAF activation 17.71
Genome-wide probing of RNA structure reveals active unfolding of mRNA structures in vivo 17.61
The effect of Foxc1 deficiency on undifferentiated and differentiated human primary keratinocytes 17.61
RNA sequencing reveals levamisole target genes PTPRZ1 and MDK and their links to interferon pathway in human podocytes 17.02
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease 16.96
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease (human) 16.96
Defective removal of ribonucleotides from DNA promotes systemic autoimmunity 16.71
Differences in miRNA Detection Levels are Technology and Sequence Dependent [NGS] 16.65
Differences in miRNA Detection Levels are Technology and Sequence Dependent 16.65
RNA sequencing of GlyH-101-treated MCF-7 cell line 16.52
RNA-seq from primary skin fibroblasts, derived of matched pairs of middle and late donor age 16.48
Aging signatures developed from a longitudinal study design are dominated by reduced transcription of genes involved in protein synthesis. 16.48
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) II 16.23
mRNA differential expression analysis in a human ex vivo model of chronic wounds 16.05
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors [RNA-seq 2] 15.77
Human SETMAR is a DNA sequence-specific histone-methylase with a broad effect on the transcriptome 15.55
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin (RNA-seq) 15.34
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin 15.34
Gene expression data from IMR90 control, IMR90 shRRM2 and shRRM2/shp16 15.32
Early transcriptome profiling of microRNA-mediated neuronal reprogramming [RNA-seq timecourse] 15.02
Next-generation sequencing of human dermal fibroblasts transdifferentiated towards the otic lineage 15.02
RNA-seq analysis of CRISPR/Cas9 generated human BMPR2 deficient endothelial cell lines harboring mutations characteristic for hereditary pulmonary hypertension (HPAH) 14.59
Long non-coding RNAs are central regulators of the IL-1b-induced inflammatory response in human lung fibroblasts 13.94
Fbxo32 mediated gene expression program underlies EMT and metastasis 13.93
GATA3-mediated chromatin reprogramming in breast cancer cells 13.84
Single Cell Sequencing Reveals Gene Expression Signatures Associated with Bone Marrow Stromal Cell Subpopulations and Time in Culture [NGS_bulk cell RNA-seq] 13.41
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers (RNA-Seq) 13.36
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers 13.36
Dynamic epigenetic remodeling underlies microRNA-mediated transdifferentiation of human adult fibroblasts into neuronal subtypes 13.17
Changes in chromatin accessibility and gene expression induced by overexpression of ONECUT transcription factors 12.9
Profiling of gene expression using RNA-Seq in fibroblasts, iPSCs, iPSC-derived neurons and cells overexpressing Onecut transcription factors 12.9
Modeling and characterization of the dynamic gene regulatory networks underlying cancer drug resistance based on time-course RNA-seq data 12.88
RNA-seq of human foreskin fibroblast cells lacking RB and/or p130 after doxorubicin treatment 12.87
Cancer Associated Fibroblasts are defined by a core set of epigenome changes that contribute to the tumor phenotype [RNA-seq] 12.7
Cancer Associated Fibroblasts are defined by a core set of epigenome changes that contribute to the tumor phenotype 12.7
Ascorbate Suppresses VEGF Expression in Retinal Pigment Epithelial Cells 12.57
Analysis of gene expression, motif and pattern of m6A modified region and m6A enrichment level in Ocular melanoma and Melanocyte cell lines. Gene expressin analysis of METTL3 knock down in PIG1, ALKBH5 knock down and HINT2 over expression in OCM1. 12.56
Identification of gene signature in ascitic fluid-isolated mesothelial cells from high grade serous ovarian cancer patients 12.19
LEDGF and HDGF2, histone H3K36 methyl-binding proteins that assist RNA polymerase II transcription through nucleosomes 12.18
Transcriptome profiling of microRNA-mediated neuronal reprogramming with REST repression at day 7 12.18
Identification of mesothelial-to-mesenchymal gene signature in ascitic fluid-isolated mesothelial cells through RNA-sequencing 12.17
RNA sequencing analysis of human podocytes reveals glucocorticoid regulated gene networks targeting non-immune pathways 12.11
High-efficiency RNA-based reprogramming of human primary fibroblasts 12.04
RNA-sequencing of fibrolamellar carcinoma (FLC) cell line treated with miR-375 mimic 12.02
Potential signaling pathways and gene signatures associated with brain metastases in NSCLC patients 11.86
PTP4A1 phosphatase is overexpressed in systemic sclerosis fibroblasts and promotes TGFb signaling 11.37
Toxoplasma controls host cyclin E expression through the use of a novel MYR1-dependent effector protein, HCE1 11.37
Rate of elongation by RNA polymerase II is influenced by specific gene features and histone modifications 11.36
Role of XRN2 ribonucleolytic activity in RNA metabolism 11.31
Transcriptional profile in dermal fibroblasts from patients with collagen VI related muscular dystrophy 11.28
Unraveling cis-regulatory elements by mapping structural changes in mRNAs 11.0
RNAseq of quiescent (Q) and stress induced premature senescent (SIPS) fibroblasts treated with plant extract (1201) from Solidago vigaurea subspecies alpestris 11.0
Next Generation RNA Sequencing Analysis of AMPK Wild Type, AMPKα-KO and AMPKα1-2A U2OS cell Transcriptomes 10.97
MOF acetyl transferase regulates transcription and respiration in mitochondria 10.95
Translocation of dense granule effectors across the parasitophorous vacuole membrane in Toxoplasma-infected cells requires the activity of ROP17, a rhoptry protein kinase 10.94
Microsatellite expansion RNA visualization, elimination, and reversal of molecular pathology by RNA-targeting Cas9 10.92
Genome-wide DNA hypomethylation and RNA:DNA hybrid accumulation in Aicardi-Goutières syndrome 10.9
Transcriptome analysis of ECFCs treated with GSK-343 and Panobinostat 10.87
Transcriptomic profiling of mesenchymal stem cells (MSC) differentiation into mesangial cells 10.57
Prostaglandin E2 inhibits pro-fibrotic function of human pulmonary fibroblasts by disrupting Ca2+-signaling 10.55
RNA-seq analysis upon ARID1B overexpression 10.24
p63 controls the enhancer landscape during keratinocyte differentiation 10.18
IMP3 regulated gene expression in breast cancer cells 9.87
Wnt addiction of genetically defined cancers reversed by PORCN inhibition 9.73
Analysis of transcriptional differences after IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 9.73
Transcriptional analysis of ZIKV-infected Ifnar-/- and Ifnar+/- placentas and IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 9.73
Control of gene expression in senescence through transcriptional read-through of convergent protein-coding genes 9.68
MYOD Gene Expression Regulation during Myogenic Conversion of Fibroblasts 9.38
Transcriptome analysis in Neobractatin treated cells 9.36
Joint-specific DNA transcriptome signatures in rheumatoid arthritis [RNA-seq] 9.33
Functional role of SLIT2 and ROBO1 in trophoblasts 9.33
ADAR1 controls apoptosis of stressed cells by inhibiting Staufen-mediated mRNA decay 9.31
MYOD Remodeling of the Genome Architecture during Myogenic Conversion of Somatic Cells 9.12
Identification and Initial Functional Characterization of SENCR, a Long Non-Coding RNA Enriched in Human Vascular Cells 9.02
Characterisation of the EZH2 regulated transcriptome in de novo transformed cells (RNA-Seq) 9.02
Genome wide mapping of long noncoding (lnc) RNAs in hepatic stellate cells 8.93
Survival of pancreatic cancer cells lacking KRAS function 8.62
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 8.61
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 [RNA-seq] 8.61
RNA sequencing and pathway analysis identify important pathways involved in hypertrichosis and intellectual disability in patients with Wiedemann-Steiner syndrome 8.44
Effect of hypoxia and TGFβ1 on gene expression in HPF fibroblast cells 8.07
RNA sequencing of Asthmatic Human Airway Smooth Muscle Cells I 7.96
Gene expression profile in endometrial organoids cultured in normal follicular phase vs PCOS-like hormone profile 7.91
Subcellular pathways shared by afflicted patients and mutant mice identify a new drug treatment for aortic aneurysm in Marfan syndrome 7.3
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence 7.17
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence [RNA-Seq] 7.17
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma 7.1
Genome-wide Analysis of Chromatin Interactions in Human Cells 7.09
Distinct regulatory programs for Sox9 in transcriptional regulation of the developing mammalian chondrocyte [RNA-seq] 7.05
Distinct regulatory programs for Sox9 in transcriptional regulation of the developing mammalian chondrocyte 7.05
RNA-SEQ assay for wild type and CRISPR induced endoglin knockout human pulmonary artery smooth muscle cells (PASMC) 6.96
FOXP2's impact on the primate transcriptome 6.84
Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells 6.67
Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells [RNA-seq] 6.67
Transcriptomic responses to Ivacaftor and prediction of Ivacaftor clinical responsiveness 6.48
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 6.35
Modulation of mitochondrial DNA copy number to induce hepatocytic differentiation of human Amniotic Epithelial cells 6.24
Inhibition of the Aryl Hydrocarbon Receptor - Polyamine Biosynthesis Axis Suppresses Multiple Myeloma and prostate cancer progression 6.23
RNA-Seq of SHEP TET21N cells upon Doxorubicin treatment 6.16
Transcriptomic analysis of effect of oncolytic measles virus (MV) on transformed and non-transformed bone marrow-derived mesenchymal stem cells (MSCs) 5.98
Transcriptional profiling of growing and senescent WT and IL-1R-depleted IMR90 cells 5.87
Human pluripotent stem cell-derived brain tumor model uncovered embryonic stem cell signature as a key driver in atypical teratoid/rhabdoid tumor (RNA-Seq) 5.77
Expression alterations induced by restoration of AXIN1 expression in SNU449 hepatocellular carcinoma cells 5.75
Differential analysis of HOXA1 in adult cells at isoform resolution by RNA-Seq [Illumina] 5.63
Differential analysis of gene regulation at transcript resolution by RNA-Seq 5.63
Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging 5.61
Expression profiling of etoposide-induced senescent cells 5.57
RNA sequence analysis of stable versus reversible EMT events and the resultant metastases 5.56
Transcriptional profiling at the DLK1/MEG3 domain explains clinical overlap between imprinting disorders 5.5
Novel Non-catalytic Substrate-selective p38α-specific MAPK Inhibitors with Endothelial-Stabilizing and Anti-inflammatory Activity 5.48
The mSWI/SNF ATPase module mediates subcomplex identity and non-catalytic targeting in SCCOHT [RNA-seq] 5.28
The ATPase module of mammalian SWI/SNF family complexes mediates subcomplex identity and catalytic activity-independent genomic targeting 5.28
Redifferentiation of expanded human islet β cells by inhibition of ARX 5.08
Integrated Systems Biology Analysis of KSHV Latent Infection Reveals Viral Induction and Reliance on Peroxisome Mediated Lipid Metabolism 5.07
Identification of a Cell-of-Origin for Fibroblasts Comprising the Fibrotic Reticulum in Idiopathic Pulmonary Fibrosis 5.03
Human Airway Smooth Muscle Transcriptome Changes in Response to Asthma Medications 4.77
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells 4.76
Epigenetic Control of Skeletal Development by the Histone Methyltransferase Ezh2 4.75
Genome-wide expression analysis of human hTert immortalized fibroblasts after donwregulation of MCM7 4.74
Next generation sequencing of human hepatic stellate cell line, LX-2 treated with recombinant human TGF-β1, with DMSO or ML290 (5 µM) for 72h. 4.71
Transcriptome analysis of RANK-positive and RANK-negative luminal progenitor subpopulations in the human breast 4.7
Expression changes in MAPKi resistant M229 melanoma lines co-cultured with PD-1 overexpressing HEK293T cells [CellLine.FPKM.batch5] 4.62
Histone acetyltransferase p300 induces de novo super-enhancers to drive cellular senescence 4.56
Histone acetyltransferase p300 induces de novo super-enhancers to drive cellular senescence [RNA-seq] 4.56
Transcriptomic analysis of senescent cells upon EXOC7 knockdown. 4.52
Transcriptome analysis of PC9 cells with gefitinib or/and hypoxia treatment and comparison with gefitinib resistant PC9 cells and ALDH positive PC9 cells 4.51
Study of dynamic transcriptome profiling in DNA damage-induced cellular senescence and transient cell-cycle arrest 4.44
TGFβ1-mediated functional inhibition of mesenchymal stromal cells in MDS and AML 4.37
A damaged genome's transcriptional landscape through multilayered expression profiling around in situ-mapped DNA double-strand breaks 4.32
Splicing and gene expression changes in human mammary epithelial MCF-10A cells expressing SR or SR-like proteins 4.32
RNA-Seq of over-expression and knockdown of the lncRNA SLNCR1 in melanoma cells 4.27
Vitamin d receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy 4.27
Allelic expression mapping across cell lineages reveal repressor disruption among disease SNPs 4.26
Re-Wiring 3D Nuclear Architecture by a Single Transcription Factor during Somatic Cell Reprogramming 4.2
Expression level comparison under dividing and quiescent states in human primary fibroblasts 4.11
An integrative network biology analysis identifies miR-508-3p as the determinant and a prognosis biomarker of the mesenchymal subtype ovarian cancer 4.11
The transcriptome of human endometrial mesenchymal stem cells under TGFβR inhibition reveals improved potential for cell-based therapies 4.09
Mutations in EBF3 disturb transcriptional profiles and cause intellectual disability, ataxia and facial dysmorphism 4.09
Downregulation of LATS kinases alters p53 to promote cell migration 4.05
Conversion of Human Fibroblasts to Stably Self-Renewing Neural Stem Cells with a Single Zinc-Finger Transcription Factor 4.05
Functional role of CPPED1 in trophoblasts. 3.94
Transcriptomic alterations in fibroblasts from Parkinson's disease patients carrying Parkin mutations 3.93
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 3.93
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics 3.87
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics (RNA-Seq) 3.87
IRF2 is a master regulator of human keratinocyte stem cell fate 3.66
IRF2 is a master regulator of human keratinocyte stem cell fate [RNA-seq] 3.66
RNA sequencing to compare gene expession in control and PF228-treated hepatic stellate cells 3.62
Functional interactions between Mi-2β and AP1 complexes control response and recovery from barrier disruption 3.59
snRNAs as regulators of alternative splicing 3.5
Targets of CDK12 on ZR-75-30 breast cancer cells (RNA-seq) 3.49
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 3.36
Postmortem Cortex Samples Identify Distinct Molecular Subtypes of ALS: Retrotransposon Activation, Oxidative Stress, and Activated Glia [shRNA] 3.36
Transcriptome of melanoma cell lines resistant to inhibition of the MAPK pathway. 3.36
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling 3.34
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling (RNA-seq) 3.34
RNA-sequencing time course of Human Intestinal Epithelial Cells (HIECs) following knockdown of miR-30bcd using complementary locked nucleic acids 3.31
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes 3.2
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes (RNA-Seq) 3.2
Morphological and molecular characterization of human dermal lymphatic collectors 3.19
Transcriptomic analysis of senescent cells upon PTBP1 knockdown and EXOC7 knockdown 3.12
Bone marrow-derived and dental pulp-derived human mesenchymal stem cell RNA-Seq 3.09
A NIK-SIX signaling axis controls inflammation by targeted silencing of noncanonical NF-κB 3.09
Functional Cardiac Fibroblasts Derived from Human Pluripotent Stem Cells via Second Heart Field Progenitors 3.08
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network 3.08
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network with PRC2 [RNA-seq] 3.08
Generation of Patient-Matched Malignant and Normal Primary Cell Cultures from Clear Cell Renal Cell Carcinoma Patients 3.08
Next Generation Sequencing of isolated EGFR+ and HLA-G+ first trimester human trophoblasts 3.06
Characterization of gene regulation and protein interaction networks for Matrin 3 encoding mutations linked to amyotrophic lateral sclerosis and myopathy 3.05
Human RELA haploinsufficiency results in autosomal dominant chronic mucocutaneous ulceration: the transcriptional profile of RelA haploinsufficient patients 2.98
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes [RNA-seq] 2.98
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes 2.98
Evolving Spindlin1 Small Molecule Inhibitors Using Protein Microarrays 2.96
GATA3 enhances the neurogenic potential of primary human astrocytes after traumatic injury [exp1] 2.91
Transcriptomic analysis of senescent cells upon PTBP1 knockdown. 2.86
Transcriptome Analysis and Functional Identification of Adipose-Derived Mesenchymal Stem Cells in Secondary Lymphedema 2.84
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. 2.72
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. [RNA-seq] 2.72
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes 2.57
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes [RNA-Seq] 2.57
The influence of PPFIA1 silencing to gene expression in breast carcinoma cell line and head and neck squamous cell carcinoma cell lines by RNA-sequencing in three dimensional collagen I 2.55
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 2.54
Single-cell transcriptomics of the human placenta: inferring the cell communication network of the maternal-fetal interface 2.53
Global loss of epigenetic and transcriptional fidility defines a subclass of cancer with immunotherapy resistance 2.51
Global gene expression profile of human peripheral blood-derived endothelial colony-forming cells is similar to coronary artery and umbilical vein endothelial cells 2.49
Transcriptional profile of human STAT1-/- fibroblasts expressing IFI6 or empty control vector 2.47
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (human cell lines RNA-Seq) 2.46
MBNL1-dependent modulation of gene expression in MDA-MB-231 breast cancer cells 2.46
Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts 2.46
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) 2.43
A sister of NANOG regulates genes expressed in pre-implantation human development 2.42
Loss of ANCO1 repression of AIB1/YAP drives breast cancer progression 2.41
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways 2.39
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways [RNA-seq] 2.39
Small molecule-mediated reprogramming of human hepatocytes into bipotent progenitor cells 2.37
An aspartyl protease defines a novel pathway for export of Toxoplasma proteins into the host cell 2.27
Widespread backtracking by RNA pol II is a major effector of gene activation, 5’ pause release, termination and transcription elongation rate 2.26
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition 2.25
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition [RNA-Seq] 2.25
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected uterine smooth muscle cells (USMC) 2.23
Evaluation of RNA amplification and RNA-Seq library preparation protocols for spermatozoa RNA profiling 2.23
SERPINA3- a novel keratinocyte differentiation promotor mediates epidermal barrier repair response in psoriatic lesion 2.23
Human induced pluripotent stem cell-derived vocal fold mucosa mimics development and responses to smoke exposure 2.21
RNA-sequencing transcriptome profiling of normal human keratinocytes differentiation 2.21
Reprogramming of human stem cells towards a rejuvenated and transformation-resisting state by recoding a single nucleotide 2.19
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_1A_PI3K_RNA-seq] 2.15
SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy 2.13
Exploring the role of macroH2A1 in transcription regulation in IMR90 primary human lung fibroblasts with RNA-seq and ChIP-seq 2.12
RNA-seq from control and macroH2A1-depleted IMR90 primary human lung fibroblasts 2.12
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells 2.12
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells (RNA-Seq) 2.12
Transcriptome profiling of 5 human adenocarcinoma cell lines 2.12
A histone H3.3 Lysine 36 Trimethylation Reader Connects Chromatin to Regulated Pre-mRNA Processing 2.08
Evolution of a transcriptional regulator from a transmembrane nucleoporin 2.06
RNA-seq in HepG2 and IMR90 cells 2.06
ENCODE Cold Spring Harbor Labs Long RNA-seq 2.06
Bladder-cancer-associated mutations in RXRA activate peroxisome proliferator-activated receptors to drive urothelial proliferation 2.06
Bladder cancer associated mutations in RXRA activate peroxisome proliferator-activated receptors 2.06
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process (RNA-seq) 2.05
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process 2.05
Transcriptome profiling identified a 3-lncRNA regulatory network in transthyretin against glucose induced hRECs dysfunction 2.03
A comparison of gene expression between lesional and non-lesional derived keratinocytes of Hailey-Hailey disease patients. 2.02
PER2 synchronizes mitotic expansion and decidual transformation of human endometrial stromal cells 2.01
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma 1.99
Epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 1.96
Gene expression profiling study by RNA-seq for identifying genes associated with epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 1.96
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency 1.94
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency (RNA-Seq) 1.94
Proximity-CLIP provides a snapshot of occupied cis-acting elements on RNA in different subcellular compartments on a transcriptome-wide scale 1.92
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 1.89
RNA-sequencing of formalin fixed human primary melanoma tissue 1.85
Global transcriptional profiling changes upon knockdown of LKB1 in human glioblastoma cell lines 1.84
The transcription and translation landscapes during human cytomegalovirus infection reveal novel host-pathogen interactions 1.84
MRTF activates TEAD-YAP target gene expression 1.82
RNA-seq of cells with TET1 knockout 1.8
The conserved transcriptional landscapes in human spermatogenesis 1.78
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors 1.78
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships 1.74
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships (RNA-seq) 1.74
Perivascular signals alter global genomic profile of glioblastoma and response to temozolomide in a gelatin hydrogel 1.74
RNA-seq of MCF10A cells and CAF 1.72
Genome wide expression change by RNF168 knocking down in NEC cells 1.7
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 1.66
Genome-Wide Transcriptional Effects of the Anti-Cancer Agent Camptothecin 1.65
The bromodomain protein BRD4 regulates splicing during heat shock 1.65
Wnt5a and its downstream transcription factor Stat3 are therapeutic targets for diffuse intrinsic pontine gliomas 1.64
Metformin induces chromosome reorganization and changes in gene expression in normal human fibroblasts 1.57
BMS-470539 on human synovial fibroblasts 1.53
DECIDUALIZATION INDUCES A SECRETOME SWITCH IN THE PERIVASCULAR NICHE CELLS OF THE HUMAN ENDOMETRIUM 1.49
Effect of hyperfractionated irradiation (HFRT) of prostate primary basal cells (PrEPs) on the transcriptome 1.48
DRB/GRO-Seq -/+ UV 1.47
Transcriptomic profile of human embryonic renal corpuscles 1.47
Understanding the Mechanistic Contribution of Herbal Extracts in Compound Kushen Injection with Transcriptome Analysis 1.46
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 1.45
Enhancer activation during EGF response 1.43
Genome-wide expression analysis of young, senescent and p38MAPK-inhibitited senescent human fibroblasts. 1.42
Chemical Enhancement of Direct Cardiac Reprogramming In Vitro and In Vivo 1.4
A role for ZNF598 in post-transcriptional gene regulation 1.38
Gene expression of thyroid cancer cell lines 1.38
Gene expression changes after depletion of Cyclin F and atypical E2Fs in HeLa cells. 1.38
Effect of OVO-like 1 knockdown on global transcript expression in differentiated BeWo trophoblast cells 1.37
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells (Poly(I:C) and LPS) 1.36
Gene expression profiling of KSHV-infected periodontal ligament cells 1.36
LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene 1.33
UBE3A-mediated regulation of imprinted genes and epigenome-wide marks in human neurons 1.32
RNA-seq in untreated and flagellin-treated Human Intestinal Myofibroblast cells (HIMF) 1.29
Coordinated regulation of synthesis and stability of RNA during the acute TNF-induced proinflammatory response 1.27
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas [RNA-Seq] 1.27
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas 1.27
The effect of very-high-molecular-mass hyaluronan (vHMM-HA) on IMR90 transcriptome 1.25
Transcriptomic profile of intestinal epithelial cells obtained from ileal endoscopic biopsies from newly-diagnosed, pediatric Crohn's disease patients and healthy controls. 1.25
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of AIM2. 1.24
UV_24h_GRO-Seq 1.24
CDK12 mediated transcriptional regulation in U2OS cells 1.24
Drug combination of 17-AAG and Belinostat on MDA-MB-231 breast cancer cells 1.22
RNA-seq of MDA-MB-231 cells with TET1 knockout 1.21
Transcriptomic analysis of LSD1 1.21
Sex-specific gene expression differences are evident in human embryonic stem cells and during in vitro differentiation of human placental progenitor cells 1.2
Next Generation Sequencing Facilitates Quantitative Analysis of Human Primary and Pluripotent Stem Cell-Derived Epicardial Cell Transcriptomes 1.19
Appropriately Differentiated ARPE-19 Cells Regain a Native Phenotype and Similar Gene Expression Profile 1.18
Expression changes in melanoma cell lines pre MAPKi treatment vs. post-MAPKi resistance (RNA-seq_CellLine.batch2) 1.16
Next Generation Sequencing Facilitated Differential Transcriptome Study of melanoma cells transduced with Notch 1 Intracellular Domain (NICD) 1.15
Nucleoporin-mediated regulation of cell identity genes 1.14
RNA-seq of human foreskin fibroblast cells lacking RB, p130, and p107 treated with doxorubicin. 1.14
Osteogenic programming of adipose-derived mesenchymal stem cells using a fungal metabolite that suppresses the Polycomb protein EZH2 1.12
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis 1.11
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis [RNA-Seq] 1.11
Integrative classification of human coding and non-coding genes based on RNA metabolism profiles 1.08
hTERT promotes cell adhesion and migration independent of telomerase activity 1.07
Transcriptome analysis of AGS cells infected with Helicobacter pylori P12 1.07
The Promyelocytic Leukemia Zinc Finger Dependent Transcriptome during Human Endometrial Stromal Cell Decidualization 1.06
DNA damage signaling mediates the functional antagonism between replicative senescence and terminal muscle differentiation 1.05
Analysis of Combined Transcriptomes Identifies Gene Modules Differentially Responding to Pathogenic Stimulation in Vascular Smooth Muscle and Endothelial Cells 1.05
Transcriptome-wide profiling of poly(A)-tail length, translation efficiency and mRNA stability using TED-seq, mRNA-seq, Ribo-seq and PRO-seq in ER stress conditions 1.04
Metabolism as an early predictor of DPSCs aging 1.04
Single cell analysis of HSV-1 infection reveals anti-viral and developmental programs are activated in distinct sub-populations with opposite outcomes 1.04
RNA-seq of exosomes identifies lncRNA profiles that distinguish early-stage esophageal squamous cell carcinoma (ESCC) from non-malignant esophagitis 1.03
Deletion of DXZ4 on the human inactive X chromosome eliminates superdomains and impairs gene silencing 1.03
Studying the selectivity of a targeted small molecule degrading a hypoxia-associated non-coding RNA 1.02
ARS2 is a general suppressor of pervasive transcription [RNAseq] 1.0
Cystathionine-β-Synthase Promotes Colon Carcinogenesis 0.98
RNAseq of Extracellular vesicle RNAs and cellular RNAs from HPASMCs with or without TGF-b1 or BMP4 treatment 0.96
microRNA suppresses prostate cancer stem cells and metastasis by inhibiting a cohort of pro-metastasis targets including CD44, Rho GTPases and EZH2 0.95
Transcriptomic insights into human decidual and peripheral blood CD8 T cells 0.94
FGF2 induces migration of human bone marrow stromal cells by increasing core-fucosylations on N-glycans of integrins 0.94
Gene expression profile of CRC-derived HILEC 0.93
High throughput analysis of three human adipose cell lines PAZ6, SGBS and SW872 0.93
Transcriptome analysis of diverse cell types infected with human cytomegalovirus [RNA-Seq] 0.92
RNA sequencing of Asthmatic Human Airway Smooth Muscle Cells II 0.92
RNA-Seq data for five HER2 over-expressed samples with twelve green fluorescent protein control samples using human mammary epithelial cells 0.92
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq 0.91
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq and microarray 0.91
Evolutionary origin and functional divergence of stem cell homeobox genes in eutherian mammals 0.89
GATA3 enhances the neurogenic potential of primary human astrocytes after traumatic injury [exp2] 0.88
Gene expression profiles of rescue with wild type or SUMO double mutant TRIM24 0.87
Gene expression profile in FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA using RNA-seq. 0.85
FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA 0.85
Ets homologous factor has critical roles in epithelial dysfunction in airway disease [RNA-seq] 0.84
Ets homologous factor has critical roles in epithelial dysfunction in airway disease 0.84
PAK4 suppresses RELB to prevent senescence-like growth arrest in breast cancer 0.84
Combined Genome and Transcriptome Sequencing to Identify Allelic Selection in Epithelial Ovarian Cancer 0.83
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome 0.81
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome 0.81
Transcriptomic profiles of human foreskin fibroblast cells in response to orf virus 0.8
Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice 0.8
miR-155 plays a crucial role in ALS and is an immune therapeutic target [RNA-Seq] 0.8
Transcriptome Sequencing of Adipose-Derived Mesechymal Stromal Cells 0.78
Differential gene expression in Jagged1 treated human dental pulp cells. 0.78
De novo reconstruction of human adipose reveals conserved lncRNAs as regulators of brown adipogenesis 0.77
RNA-sequencing of isogenic primary, pre-malignant immortalized, and Ras-transformed human mammary epithelial cells 0.77
ADAR1-editing in HeLa, p150-KO and ADAR1-KO transcriptomes 0.74
ADAR1-editing of cellular and measles virus-derived duplex RNA 0.74
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes [RNA-seq] 0.73
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes. 0.73
RNA sequencing of human pancreatic cancer cell lines 0.72
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines 0.71
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines (mRNA-Seq) 0.71
Transcriptomic analysis of the HOTAIR-regulated genes 0.71
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 0.7
Flura-seq identifies organ-specific adaptations in metastasis-initiating cells 0.65
Role of CD133 molecule in WNT response and renal repair 0.64
Gene expression profiles in HMC3 cells after exposure to ketamine or its active metabolites: 2R6R-HNK and 2S6S-HNK 0.62
Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression 0.61
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes 0.6
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes: Singapore Cohort RNA-seq 0.6
Gene Expression of Breast Cancer Cell Lines Across Biomaterial Platforms 0.58
The histone variant H3.3 G34W substitution in giant cell tumor of the bone link chromatin and RNA processing [RNA-seq] 0.57
Genome models integrating chromatin contacts and nuclear lamin-genome interactions reveal implications of laminopathy-causing lamin mutations on genome architecture 0.57
HEK293 Heat-shock experiment 0.56
Gene expression analysis of a panel of human fibroblasts that generate an aligned (anisotropic) vs non-aligned extracellular matrix 0.55
Analysis of the senescent transcriptome upon expression of a ZFP36L1 phosphomutant 0.54
RNASeq of mouse, human, and non-human primate primary dermal fibroblasts to poly(I:C) transfection 0.54
Patient-derived organoids (PDOs) model treatment response of metastatic gastrointestinal cancers. 0.53
RNA-seq data of small cell carcinoma of the bladder (SCCB) /urothelial carcinoma (Non-SCCB) clinical samples, and bladder-PARCB cell lines 0.52
RNA profiling Analysis of the Serum Exosomes Derived from Active and Latent M.tuberculosis infectious Patients 0.52
Reprogramming postnatal human epidermal keratinocytes toward functional neural crest fates 0.49
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 0.48
RNA-seq in endometrial stromal tumors 0.48
EIF1AX-A113 splice and RAS mutations cooperate to drive thyroid tumorigenesis through ATF4 and c-MYC 0.48
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis 0.47
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis [RNA-Seq] 0.47
A code of mono-phosphorylation modulates the function of RB. 0.45
Immune Checkpoint Regulation of Pulmonary Fibrosis [bulk RNA-seq] 0.45
Sequencing of freshly produced RNA following exposure of cells to DNA damage-inducing UV mimetic 4-hydroxyaminoquinolone (4-NQO) 0.44
CRISPR-Cas9 combinatorial KO of epigenetic regulators in human ovarian cancer cells 0.44
Epigenetic activation and memory at a TGFB2 enhancer in systemic sclerosis 0.43
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection [RNA-seq] 0.42
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection 0.42
Global unleashing of transcription elongation waves in response to genotoxic stress restricts somatic mutation rate 0.4
Reciprocal Reprogramming of Cancer Cells and Associated Mesenchymal Stem Cells in Gastric Cancer. 0.39
Diarrhea in lymphocytic colitis: ERK1/2-dependent ENaC dysregulation and claudin-4-, -5- and -8-related barrier defects 0.38
Direct identification of endogenous SMG6 targets and a preferred motif spanning SMG6 cleavage sites by parallel analysis of RNA ends in human cells 0.37
Human Cactin interacts with DHX8 and SRRM2 to assure efficient pre-mRNA splicing and sister chromatid cohesion. 0.35
RNA sequencing analysis of selumetinib-resistant CRC cells lines 0.35
Rational targeting of RNA structure in SMN2 transcripts reverses Spinal Muscular Atrophy molecular phenotypes 0.34
Next Generation Sequencing Analysis of Colorectal Cancer Tissue Transcriptomes 0.33
Characterization of parental and rociletinib-resistant derived H1975 cell lines 0.32
Pancreatic Beta Cell Enhancers Regulate Rhythmic Transcription of Exocyst Triggering and Diabetes 0.32
Genome-wide Circadian Control of Transcription at Active Enhancers Regulates Insulin Secretion and Diabetes Risk 0.32
Steroid Receptor Coactivator-2 Regulated Transcriptome in Human Endometrial Stromal Cells 0.31
Dexamethasone inhibits respiratory syncytial virus-driven mucus production while increasing viral replication without altering antiviral interferon signaling 0.3
Browning of human adipocytes requires KLF11 and reprogramming of PPARγ super-enhancers 0.29
Stapled peptide inhibitors of RAB25 target context-specific phenotypes in cancer 0.29
OBESITY IS ASSOCIATED WITH IMPAIRED EXPRESSION OF THE GLYCOSYLTRANSFERASE EOGT IN DECIDUALIZING ENDOMETRIUM 0.28
Identification of Sin3B regulated genes during quiescence 0.26
Transcriptome analysis of diverse cell types infected with human cytomegalovirus 0.25
Ribosomal protein RPL26 is the principal target of UFMylation 0.23
Bi-allelic Alteration and Dysregulation of the Hippo Pathway in Mucinous Tubular and Spindle Cell Carcinoma of the Kidney 0.23
Efficient direct reprogramming of c-Kit− mature amniotic cells into endothelial cells by ETS factors and TGFβ suppression 0.23
A bioinformatics approach reveals novel mechanisms of the OVOL transcription factors in the regulation of epithelial-mesenchymal cell programming and cancer progression. 0.23
Aberrant expression profile of lncRNA and mRNA in dilated cardiomyopathy by RNA-sequence 0.22
Ex vivo expanded human 3D Nephrospheres engraft long term and repair chronic renal injury in mice 0.22
DLX3 alters transcriptomic profile of adhesion, cell cycle, and cell death in Squamous Cell Carcinoma Cells 0.21
DLX3-dependent p53 signaling network controls keratinocyte cell cycle and squamous tumor growth 0.21
iPSC-Derived Cholangiocytes 0.19
Regulation of hypoxia-inducible factor activity by ZMYND8 0.18
RNA-Seq of Breast and Ovarian Cancer Cell Lines 0.18
Deep RNA sequencing of the human placental transcriptome 0.17
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. 0.16
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. 0.16
Priming mobilization of hair follicle stem cells triggers permanent loss of regeneration after alkylating chemotherapy 0.16
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 & MCM7 0.16
Reprogramming of dermal papilla cell intact gene signature with 3D culture and Lef-1 overexpression 0.15
mRNAseq of Huntington's disease and control patient iPSC-derived brain microvascular endothelial cells 0.13
A Basal Stem Cell Signature Identifies Aggressive Prostate Cancer Phenotypes 0.11
Expression charcaterization of an internal protocol developed to differentiate RPE cells 0.11
Biased Expression of the FOXP3Δ3 Isoform in Aggressive Bladder Cancer Mediates Differentiation and Cisplatin Chemotherapy Resistance 0.1
Gene expression profiles of active and restricted R/G-HIV+ primary human fetal astrocytes 0.1
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG 0.08
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG functional reactivation [human cells RNA-seq] 0.08
RNAseq analysis of ruxolitinib treated breast cancers 0.08
Genome-wide analysis of the Integrator complex (HTS) 0.07
Genome-wide analysis of the Integrator complex 0.07
E2F1 orchestrates transcriptomics and oxidative metabolism in Wharton’s jelly derived mesenchymal stem cells from growth-restricted neonates 0.07
Impact of library preparation on downstream analysis and interpretation of RNA-seq data: comparison between Illumina PolyA and NuGEN Ovation protocol 0.07
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders [lnc-Nr2f1 overexpression] 0.06
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders 0.06
UV-Irradiation Induces a Noncoding RNA that Functionally Opposes the Protein Encoded by the Same Gene 0.05
Mutant p63 disrupts the key specification switch from the multipotent cell state to stratified epithelia during epithelial differentiation/in ectodermal dysplasia disorders 0.03
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency [RNA-Seq] 0.03
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency 0.03
Whole transcriptome sequencing of the human thyroid primary cells with knock-down of the NRG1 gene 0.03
Gene expression for surgically treated pancreatic cancer after one neoadjuvant vaccine dose 0.03
The DNA methylation landscape of human melanoma 0.02
The DNA methylation landscape of human melanoma [RNA-Seq] 0.02
ML29755 RNA-seq data 0.02
RNA sequencing of prostate cancer and normal tissue from African Americans and European Americans 0.02
Gene expression analysis of human adenomas. 0.02
RNAseq data from Mesenchymal stem cells treated with TCDD or 1-methyl tryptophan 0.0
Next Generation Sequencing of Lung Primary Fibroblast Responding to Eosinophil-Degranulation Products 0.0
Mouse Dux is myotoxic and shares partial functional homology with its human paralog DUX4 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation